ACM
ITOS

Aquatic Capital Management’s iTeos Therapeutics ITOS Stock Holding History

Aquatic Capital Management’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,500
Closed -$15.3K – 1471
2024
Q3 		$15.3K Buy
+1,500
New +$22.9K ﹤0.01% 1064
2023
Q3 		– Sell
-1,400
Closed -$19K – 1446
2023
Q2 		$19K Buy
+1,400
New +$20K ﹤0.01% 1138

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Aquatic Capital Management's ITOS Position: Q4 2024 in Review

Aquatic Capital Management sold out of iTeos Therapeutics (ITOS) in Q4 2024, closing a stake of 1,500 shares — an estimated $15.3K sold.

Aquatic Capital Management first reported a position in ITOS in Q2 2023 and held it in 2 quarters. The position peaked at $19K in Q2 2023. 136 funds tracked by Wall St. Rank hold ITOS as of Q4 2024.

  • Aquatic Capital Management reported no remaining iTeos Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Aquatic Capital Management sold 1,500 iTeos Therapeutics shares in Q4 2024, an estimated $15.3K.
  • Aquatic Capital Management first reported a position in iTeos Therapeutics in Q2 2023 and held it in 2 quarters.
  • Aquatic Capital Management's iTeos Therapeutics position peaked at $19K in Q2 2023.
  • 136 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2024.

Based on Aquatic Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.